Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical Value of Detecting MYD88 L265P Mutation in the Plasma of Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma via Droplet Digital PCR].

Zhongguo shi yan xue ye xue za zhi - 1 Apr 2026

Li Lu-Yang, Yang Yu-Chao, Zhang Min, Wen Xiao-Lian, Tian Zhuan-Zhuan, Li Jing, Su Hong, Zhang Hong-Wei, Yu Bao-Feng, Su Li-Ping, Guan Tao

Abstract excerpt

OBJECTIVE: To detect the MYD88 L265P mutation in cell-free DNA (cfDNA) from the plasma of patients with treatment-naive diffuse large B-cell lymphoma (DLBCL) using droplet digital PCR (ddPCR) technology, and to explore its associations with clinicopathological parameters, treatment response, and prognosis. METHODS: Plasma samples from 158 patients with treatment-naive DLBCL were collected. cfDNA in the plasma was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to MYD88 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Large B-Cell, Diffuse

Share to Mutation

Share to Myeloid Differentiation Factor 88

Share to Polymerase Chain Reaction

Share to Prognosis

Source

Identifiers

PMID: 42227430
DOI: 10.19746/j.cnki.issn1009-2137.2026.02.011

Genes

MYD88

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical Value of Detecting MYD88 L265P Mutation in the Plasma of Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma via Droplet Digital PCR].PMID 42227430Read ↗

Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.Semantic proximity Read ↗

MYD88 L265P Mutation Detection by ddPCR: Recommendations for Screening and Minimal Residual Disease Monitoring : ddPCR for Highly Sensitive Detection of MYD88 L265P Mutation.Semantic proximity Read ↗

Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain ReactionSemantic proximity Read ↗

MYD88 L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker.Semantic proximity Read ↗

Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma.Semantic proximity Read ↗

MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era.Semantic proximity Read ↗

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation.Semantic proximity Read ↗

Expression of MYD88 L265P Mutation in Subtypes of Diffuse Large B-Cell Lymphoma in the Pakistani Population.Semantic proximity Read ↗

Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients.Semantic proximity Read ↗

Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.Semantic proximity Read ↗

Guiding treatment and clinical management of patients with CNS lymphomas by minimal-invasive detection of circulating tumor DNA in cerebrospinal fluidSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.